FindTrial
Sign In

Device validation study for detecting likely presnce of Pulmonary Tuberculosis

Swaasa Artificial Intelligence Platform for detecting likely presence of Pulmonary Tuberculosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036609
Enrollment
200
Registered
2021-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A159- Respiratory tuberculosis unspecified

Interventions

None listed

Sponsors

Cellular and Molecular Platforms
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male or female patients, 18 years of age and over Patients who are willing to participate in the study. Able to read understand and sign the Informed Consent Form

Exclusion criteria

Exclusion criteria: Patients less than 18 years of age Pregnant females. Presumptive PTB patients with coexisting other respiratory diseases like COPD, Bronchiectasis, ILDs Who are not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
Validation of the SWAASA AI Platform in detecting likely presence of PTB by comparing with the final clinical diagnosis based on test results of a standard reference test or tests.Timepoint: 5 months—

Secondary

MeasureTime frame
Evaluate the effectiveness of Swaasa AI platform in detecting PTB in a primary health care settingTimepoint: 2 months—

Countries

India

Contacts

Public ContactNarayana Rao Sripada

Andhra Medical College

gayatriyellapu@gmail.com8688546233

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026